Abstract Views :296 |
PDF Views:80
Authors
Affiliations
1 Department of Medical Biotechnology, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok 737 102, IN
2 Department of Medicine, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok 737 102, IN
3 Department of Biochemistry, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok 737 102, IN
Source
Current Science, Vol 117, No 11 (2019), Pagination: 1768-1769
Abstract
Diabetic nephropathy (DN) is one of the most common causes of end-stage renal disease (ESRD). Despite major advances made in the area of diagnosis and treatment of DN, death cases related to this ailment are not significantly reduced. Thus it is important to identify the risk factors for this condition.
Full Text
References
- Singh, D. K., Winocour, P. and Farrington, K., Nature Rev. Endocrinol., 2011, 7, 176– 184.
- Piedrafita, F. J., Molander, R. B., Vansant G, Orlova, E. A., Pfahl, M. and Reynolds, W. F., J. Biol. Chem., 1996, 271, 14412– 14420.
- The Diabetes Control and Complications (DCCT) Research Group. Kidney Int., 1995, 47, 1703–1720.
- Rovira-Llopis, S., Rocha, M., Falcon, R., de Pablo, C., Alvarez, A., Jover, A. and Hernandez-Milares, A., Antioxid. Redox Signal., 2013, 19, 1452–1458.
- Ministry of Health and Family Welfare, Government of India, National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke 2013. Available from: pib.nic.in/newsite/PrintRelease.
